Alexion CEO Hantson Tasked With Kicking Growth Momentum Into Gear

The rare disease specialist’s new CEO is former Baxalta CEO Ludwig Hantson, who takes over the helm immediately after a leadership shakeup coinciding with an audit investigation.

Hantson_Ludwig_1200x675
Alexion CEO Ludwig Hantson

Alexion Pharmaceuticals Inc.’s new CEO Ludwig Hantson will need to refocus the rare disease specialist onto a steady growth track after the company's recent missteps. Alexion announced the appointment of Hantson, formerly Baxalta Inc.'s CEO, on March 27.

Hantson succeeds David Brennan, who stepped in on an interim basis in December after former CEO David Hallal resigned for...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Scrip